AMYLOID FIBRIL-SPECIFIC CHIMERIC ANTIGEN RECEPTOR MACROPHAGES (CAR-M)-BASED IMMUNOTHERAPY FOR AMYLOID CLEARANCE IN LIGHT CHAIN AMYLOIDOSIS
$161,999FY2021Department of the ArmyDOD
The Trustees Of Columbia University In The City Of New York
The Trustees Of Columbia University In The City Of New York